BioLine RX Stock

BioLine RX Stocks

The The number of shares of BioLine RX (BLRX.TA) as of Mar 21, 2026 is 1.2 B.In the previous year, The number of shares was 1.2 B — a change of 0% (lower).

Stocks

1.2 B

YoY

0%

Last updated:

In 2026, BioLine RX had 1.2 B outstanding stocks, a 0% change from the 1.2 B stocks in the previous year.

The BioLine RX Stocks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

NUMBER OF STOCKS (B USD)
Date
NUMBER OF STOCKS (B USD)
Jan 1, 2005
0.01 base
Jan 1, 2006
0.01 base
Jan 1, 2007
0.01 base
Jan 1, 2008
0.01 base
Jan 1, 2009
0.01 base
Jan 1, 2010
0.01 base
Jan 1, 2011
0.01 base
Jan 1, 2012
0.02 base
Jan 1, 2013
0.02 base
Jan 1, 2014
0.03 base
Jan 1, 2015
0.05 base
Jan 1, 2016
0.06 base
Jan 1, 2017
0.09 base
Jan 1, 2018
0.11 base
Jan 1, 2019
0.15 base
YEARNUMBER OF STOCKS (B USD)
2024 1.2
2023 0.96
2022 0.77
2021 0.66
2020 0.25
2019 0.15
2018 0.11
2017 0.09
2016 0.06
2015 0.05
2014 0.03
2013 0.02
2012 0.02
2011 0.01
2010 0.01
2009 0.01
2008 0.01
2007 0.01
2006 0.01
2005 0.01
Access this data via the Eulerpool API
Get Free API Key

BioLine RX Shares Outstanding

BioLine RX shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2005
6.14 M base_Shares
Jan 1, 2006
6.14 M base_Shares
Jan 1, 2007
5.4 M base_Shares
Jan 1, 2008
6.38 M base_Shares
Jan 1, 2009
9.76 M base_Shares
Jan 1, 2010
12.45 M base_Shares
Jan 1, 2011
12.36 M base_Shares
Jan 1, 2012
16.94 M base_Shares
Jan 1, 2013
22.49 M base_Shares
Jan 1, 2014
32.43 M base_Shares
Jan 1, 2015
51.41 M base_Shares
Jan 1, 2016
56.14 M base_Shares
Jan 1, 2017
89.97 M base_Shares
Jan 1, 2018
108.6 M base_Shares
Jan 1, 2019
146.41 M base_Shares

BioLine RX Stock analysis

What does BioLine RX do? BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe. BioLine RX is one of the most popular companies on Eulerpool.

Stocks Details

Evaluating BioLine RX's Shares Outstanding

BioLine RX's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in BioLine RX’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding BioLine RX’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in BioLine RX’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about BioLine RX stock

The number of shares of BioLine RX amounted to 1.2 B 1.2 B

Access this data via the Eulerpool API
Get Free API Key

Other — BioLine RX

StocksSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — BioLine RX